Diagnosis of dementia utilizing thrombospondin

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/68 (2006.01)

Patent

CA 2473866

A method for diagnosing various forms of dementia, including MCI, and Alzheimer's disease (AD) is disclosed. The method involves directly detecting the presence of a biochemical marker, specifically thrombospondin, in bodily fluid, preferably blood or a blood product. The detection is by an immunoassay incorporating an antibody specific to thrombospondin, or alternatively an autoantibody to a thrombospondin antibody.

L'invention porte sur un procédé de diagnostic de différentes formes de la démence telle que la déficience cognitive légère et la maladie d'Alzheimer. Le procédé consiste à détecter directement la présence d'un marqueur biochimique, notamment la thrombospondine, dans un fluide biologique, de préférence le sang ou un produit sanguin. Cette détection s'effectue par dosage immunologique comprenant un anticorps spécifique de la thrombospondine ou alternativement un auto-anticorps contre un anticorps de la thrombospondine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diagnosis of dementia utilizing thrombospondin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis of dementia utilizing thrombospondin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of dementia utilizing thrombospondin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1785067

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.